Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin.

MacIsaac J, Siddiqui R, Jamula E, Li N, Baker S, Webert KE, Evanovitch D, Heddle NM, Arnold DM.

Transfusion. 2018 Nov;58(11):2729-2735. doi: 10.1111/trf.14841. Epub 2018 Sep 23. Review.

PMID:
30244480
2.

Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.

Oaklander AL, Lunn MP, Hughes RA, van Schaik IN, Frost C, Chalk CH.

Cochrane Database Syst Rev. 2017 Jan 13;1:CD010369. doi: 10.1002/14651858.CD010369.pub2. Review.

3.

Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Mahdi-Rogers M, Brassington R, Gunn AA, van Doorn PA, Hughes RA.

Cochrane Database Syst Rev. 2017 May 8;5:CD003280. doi: 10.1002/14651858.CD003280.pub5. Review.

PMID:
28481421
4.

Efficacy and safety of biologic therapies for systemic lupus erythematosus treatment: systematic review and meta-analysis.

Borba HH, Wiens A, de Souza TT, Correr CJ, Pontarolo R.

BioDrugs. 2014 Apr;28(2):211-28. doi: 10.1007/s40259-013-0074-x. Review.

PMID:
24190520
5.

Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.

Lunn MP, Nobile-Orazio E.

Cochrane Database Syst Rev. 2016 Oct 4;10:CD002827. Review.

6.

Immunomodulatory Treatments with Intravenous Immunoglobulin [Internet].

Kornør H, Hammerstrøm KT, Brurberg KG, Klemp Gjertsen M, Frøland S.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2008 Jul.

7.

Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.

Gorson KC, Natarajan N, Ropper AH, Weinstein R.

Muscle Nerve. 2007 Jan;35(1):66-9.

PMID:
16967492
8.
9.
10.

Intravenous immunoglobulin for Guillain-Barré syndrome.

Hughes RA, Swan AV, van Doorn PA.

Cochrane Database Syst Rev. 2014 Sep 19;(9):CD002063. doi: 10.1002/14651858.CD002063.pub6. Review.

PMID:
25238327
11.

Intravenous immunoglobulin in autoimmune neuromuscular diseases.

Dalakas MC.

JAMA. 2004 May 19;291(19):2367-75. Review.

PMID:
15150209
12.

[Intravenous immunoglobulin (IVIG)].

Hara M.

Nihon Rinsho. 2009 Mar;67(3):599-605. Review. Japanese.

PMID:
19280939
13.

Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].

LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep.

14.

Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia.

Bauer K, Rancea M, Roloff V, Elter T, Hallek M, Engert A, Skoetz N.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD008079. doi: 10.1002/14651858.CD008079.pub2. Review.

PMID:
23152253
15.

Intravenous immunoglobulin for myasthenia gravis.

Gajdos P, Chevret S, Toyka KV.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD002277. doi: 10.1002/14651858.CD002277.pub4. Review.

PMID:
23235588
16.

Intravenous immunoglobulin in the therapeutic armamentarium of systemic lupus erythematosus: a systematic review and meta-analysis.

Sakthiswary R, D'Cruz D.

Medicine (Baltimore). 2014 Oct;93(16):e86. doi: 10.1097/MD.0000000000000086. Review.

17.

Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.

Gürcan HM, Ahmed AR.

Ann Pharmacother. 2007 May;41(5):812-23. Epub 2007 Apr 17. Review.

PMID:
17440006
18.

Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review.

Fergusson D, Hutton B, Sharma M, Tinmouth A, Wilson K, Cameron DW, Hebert PC.

Transfusion. 2005 Oct;45(10):1640-57. Review.

PMID:
16181216
19.

Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.

Gaebel K, Blackhouse G, Campbell K, Robertson D, Xie F, Assasi N, Chalk C, Levine M, Goeree R.

Open Med. 2010;4(3):e154-66. Epub 2010 Aug 24.

20.

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.

Eftimov F, Winer JB, Vermeulen M, de Haan R, van Schaik IN.

Cochrane Database Syst Rev. 2013 Dec 30;(12):CD001797. doi: 10.1002/14651858.CD001797.pub3. Review.

PMID:
24379104

Supplemental Content

Support Center